Physician profile
Baxter D Montgomery
NPI 1295728293
$8,401.18
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,225 · 2020: $125 · 2021: $307 · 2022: $341 · 2023: $301 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $6,857.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $301.46 | 2019-2022 | |
| Novo Nordisk INC | $156.24 | 2021-2023 | Ozempic |
| Janssen Scientific Affairs, LLC | $131.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $117.64 | 2019 | |
| Tactile Systems Technology INC | $99.84 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.80 | 2019-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $71.08 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.83 | 2019-2021 | |
| Biotronik INC. | $54.12 | 2019 | |
| Cvrx, INC. | $52.19 | 2022-2023 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $47.97 | 2024 | Onpattro |
| Boston Scientific Corporation | $47.14 | 2020-2022 | |
| Medtronic Vascular, INC. | $42.83 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $38.36 | 2023 | Inpefa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $35.66 | 2024 | Edarbi |
| Bardy Diagnostics, INC. | $34.19 | 2020-2022 | |
| Abbott Laboratories | $31.73 | 2021-2022 | |
| Esperion Therapeutics, INC. | $27.85 | 2021 | |
| Amarin Pharma, INC. | $26.01 | 2020 | |
| Scpharmaceuticals INC. | $17.80 | 2024 | |
| Medtronic, INC. | $15.26 | 2022 | |
| Amgen INC. | $12.22 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.89 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baxter Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.